0001786205-19-000003.txt : 20191015 0001786205-19-000003.hdr.sgml : 20191015 20191015143757 ACCESSION NUMBER: 0001786205-19-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191015 DATE AS OF CHANGE: 20191015 EFFECTIVENESS DATE: 20191015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arcellx, Inc. CENTRAL INDEX KEY: 0001786205 IRS NUMBER: 472855917 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-347172 FILM NUMBER: 191150679 BUSINESS ADDRESS: STREET 1: 25 WEST WATKINS MILL ROAD STREET 2: SUITE A CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-723-6641 MAIL ADDRESS: STREET 1: 25 WEST WATKINS MILL ROAD STREET 2: SUITE A CITY: GAITHERSBURG STATE: MD ZIP: 20878 D/A 1 primary_doc.xml X0708 D/A LIVE 0001786205 Arcellx, Inc. 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD MARYLAND 20878 240-723-6641 DELAWARE Encarta Therapeutics, Inc. None Corporation true 2014 David Hilbert c/o Arcellx, Inc. 25 West Watkins Road, Suite A Gaithersburg MD MARYLAND 20878 Executive Officer Director Han Lee c/o Arcellx, Inc. 25 West Watkins Road, Suite A Gaithersburg MD MARYLAND 20878 Executive Officer Ali Behbahani c/o Arcellx, Inc. 25 West Watkins Road, Suite A Gaithersburg MD MARYLAND 20878 Director Tiba Aynechi c/o Arcellx, Inc. 25 West Watkins Road, Suite A Gaithersburg MD MARYLAND 20878 Director Jill Carroll c/o Arcellx, Inc. 25 West Watkins Road, Suite A Gaithersburg MD MARYLAND 20878 Director Roger Sawhney c/o Arcellx, Inc. 25 West Watkins Road, Suite A Gaithersburg MD MARYLAND 20878 Director Hugo Beekman c/o Arcellx, Inc. 25 West Watkins Road, Suite A Gaithersburg MD MARYLAND 20878 Director Lewis T. Rusty Williams c/o Arcellx, Inc. 25 West Watkins Road, Suite A Gaithersburg MD MARYLAND 20878 Director Biotechnology Decline to Disclose 06b true 0001786205-19-000001 2019-08-09 false true false 0 83681224 42840613 40840611 false 18 0 0 0 false Arcellx, Inc. /s/ David Hilbert David Hilbert President & CEO 2019-10-14